1.
2.
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets
(feeds.content.dowjones.io)
3.
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
(feeds.content.dowjones.io)
4.
5.
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists
(news.ycombinator.com)
6.
Heart Attack and Stroke Risk Jumps When People Stop Taking GLP-1s
(news.ycombinator.com)
9.
Don't lick that cold metal pole in winter—if you do, don't panic
(arstechnica.com)
10.
11.
What is the science behind ‘science-backed’ supplements?
(feeds.nature.com)
13.
ChatGPT Health fails to recognise medical emergencies – study
(news.ycombinator.com)
14.
Experts sound alarm after ChatGPT Health fails to recognise medical emergencies
(news.ycombinator.com)
15.
A psychedelic medicine performs well against depression
(news.ycombinator.com)
16.
Host control of persistent Epstein–Barr virus infection
(feeds.nature.com)
17.
18.
19.
Drugmakers raise US prices on 350 medicines despite pressure
(news.ycombinator.com)
20.
21.
22.
Failure is not an option for Africa’s newly launched medicines agency
(feeds.nature.com)
23.
Africa Finally Has Its Own Drug-Regulation Agency
(slashdot.org)
24.
25.
OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation
(techcrunch.com)
27.
Lewis and Clark marked their trail with laxatives
(news.ycombinator.com)
28.
Why Exercise Is a Miracle Drug
(news.ycombinator.com)
29.
Nearly 20% of cancer drugs defective in four African nations
(news.ycombinator.com)
30.
Nearly 20% of cancer drugs defective in 4 African nations
(news.ycombinator.com)